期刊文献+

中国胃肠间质瘤诊断治疗共识(2013年版) 被引量:97

原文传递
导出
摘要 近年来,胃肠间质瘤(gastrointe stinalstromal tumors.GIST)的诊断、治疗和研究进展迅速。为了进一步推动GIST的规范化诊断和治疗。建立包括病理科、影像科、外科、肿瘤内科和消化内科等在内的多学科合作模式,有必要制定专家共识或临床实践指南作为重要参考,既往的中国胃肠间质瘤诊断治疗共识(2011年版)曾经发挥了积极作用。在随后的2年里,CSCO胃肠间质瘤专家委员会对于该共识.多次组织专家讨论,根据最新的文献资料进行修改补充,广泛征求意见,由此形成中国胃肠间质瘤诊断治疗共识(2013年版),现予公布。
出处 《中华胃肠外科杂志》 CAS CSCD 2014年第4期393-398,共6页 Chinese Journal of Gastrointestinal Surgery
  • 相关文献

参考文献4

二级参考文献51

  • 1贺慧颖,项一宁,李燕,钟镐镐,吴秉铨,郑杰.胃肠道间质瘤60例中c-kit和PDGFRA基因突变的检测[J].北京大学学报(医学版),2005,37(3):320-324. 被引量:10
  • 2[1]Hirota S,Isozaki K,Moriyama Y,Hashimoto K,Nishida T,Ishiguro S,Kawano K,Hanada M,Kurata A,Takeda M,Muhammad Tunio G,Matsuzawa Y,Kanakura Y,Shinomura Y,Kitamura Y.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.Science 1998;279:577-580
  • 3[2]Joensuu H,Roberts PJ,Sarlomo-Rikala M,Andersson LC,Tervahartiala P,Tuveson D,Silberman S,Capdeville R,Dimitrijevic S,Druker B,Demetri GD.Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.N Engl J Med 2001;344:1052-1056
  • 4[3]Demetri GD,von Mehren M,Blanke CD,Van den Abbeele AD,Eisenberg B,Roberts PJ,Heinrich MC,Tuveson DA,Singer S,Janicek M,Fletcher JA,Silverman SG,Silberman SL,Capdeville R,Kiese B,Peng B,Dimitrijevic S,Druker BJ,Corless C,Fletcher CD,Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med 2002;347:472-480
  • 5[4]Verweij J,Casali PG,Zalcberg J,LeCesne A,Reichardt P,Blay JY,Issels R,van Oosterom A,Hogendoorn PC,Van Glabbeke M,Bertulli R,Judson I.Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib:randomised trial.Lancet 2004;364:1127-1134
  • 6[5]Scaife CL,Hunt KK,Patel SR,Benjamin RS,Burgess MA,Chen LL,Trent J,Raymond AK,Cormier JN,Pisters PW,Pollock RE,Feig BW.Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg 2003;186:665-669
  • 7[6]Bauer S,Hartmann JT,de Wit M,Lang H,Grabellus F,Antoch G,Niebel W,Erhard J,Ebeling P,Zeth M,Taeger G,Seeber S,Flasshove M,Schutte J.Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.Int J Cancer 2005;117:316-325
  • 8[7]Chacon M,Roca E,Huertas E,Loria FS,Domenechini E.CASE 3.Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.J Clin Onco12005;23:1580-1582
  • 9[8]Salazar M,Barata A,Andre S,Venancio J,Francisco I,Cravo M,Nobre-Leitao C.First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy.Gut 2006;55:585-586
  • 10[9]Bonvalot S,Eldweny H,Pechoux CL,Vanel D,Terrier P,Cavalcanti A,Robert C,Lassau N,Cesne AL.Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.Ann Surg Oncol 2006;13:1596-1603

共引文献305

同被引文献616

引证文献97

二级引证文献401

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部